ArticleHaematologica2009

CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure.

Nathalie A Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.